×
Logging into your profile is required to purchase, complete, and print certificates for AAHFN CE Educational Courses.
Already a member? Log In
Not a member? Join Now
Create a non-member profile? Create Profile
Transforming the Care of Diabetes and Heart Disease in 2021: The Rise of the SGLT2 Inhibitors - Prevention
Transforming the Care of Diabetes and Heart Disease in 2021: The Rise of the SGLT2 Inhibitors
Enduring Education Activity
Expiration Date: May 2023
Learning Outcomes
The participant will be able to effectively identify the complications associated with increased mortality related to diabetes including heart failure and CVD, effectively educate on the use of SGLT2, and will self-report knowledge and how to access and incorporate SGLT2's in practice.
Planning Committee
Ashlee Whelan, RN
Faculty
Jonathan D. Rich, MD